It’s likely the Braves will make another addition before opening day. They’ve done so in the past – Anthopoulos pointed out Matt Joyce, who was acquired just before the 2019 season and played an important bench role for a 97-win team. There were numerous other unheralded contributors over the past three seasons, including starter Anibal Sanchez, utilityman Charlie Culberson, infielders Ryan Flaherty and Adeiny Hechavarria, outfielders Preston Tucker and Billy Hamilton, relievers Anthony Swarzak and Luke Jackson, among others.
The Braves are in their current predicament because when they determined the best use of their offseason resources, they invested in their rotation and the middle of their lineup. They spent the bulk of their money on starters Charlie Morton and Drew Smyly, along with re-signing slugger Marcell Ozuna. The realities of the pandemic forced the Braves to cut payroll, limiting their ability to improve.
“Look, our payroll is down from where it was in 2020. You have to make some tough calls,” Anthopoulos said. “That’s where I feel like our depth is going to be impacted, our bench is going to be impacted. We don’t have an Adam Duvall waiting in the wings. Maybe somebody emerges like a Matt Joyce, who we picked up at the end of 2019 spring training. Right now, we obviously didn’t pour a lot of resources into the bench because we allocated our dollars in other areas, whether that’s Morton, Smyly, Ozuna, and that was with an Ozuna backload (contract).
“So there’s certain areas, even in the bullpen as well, that we had to make some tough calls. We’re going to need to have some upside and hopefully some guys emerge and take a step. That’s just the reality of things. That’s not a complaint. It’s just part of the challenge. The likelihood that hopefully we’re contending at the trade deadline and we’re looking to add in some areas - or maybe we end up having a strong group and they have great years.”
Indeed, if the Braves are contending and are buyers at the trade deadline, Anthopoulos doesn’t anticipate money preventing them from reasonably upgrading their roster. He said ownership has assured him some flexibility.
“No doubt,” Anthopoulos said. “I have been told that. I don’t have any doubt about that. Come July, we’re in a position to do things - I think things are starting to look up in terms of (COVID-19) vaccines. You see every team now looks like they’ll have fans. Obviously Toronto is playing in Florida. But it’s a very different outlook than it was three months ago. It looks like things will continue to get better, more and more people are getting vaccinated. I think we’re very optimistic that come July, things will be a lot better.”
Perhaps the depth situation improves in the coming weeks. One of the Braves’ bench candidates might become a pleasant surprise. They might add somebody before April 1 who becomes an instrumental part of the club. Maybe Jackson, Contreras, Camargo or Inciarte makes the most of his opportunities. There are endless variables that would change the conversation.
But for now, the bench is a major question mark. It will be an ongoing story, good or bad, throughout the year.
“Again, having to make some tough calls, tough decisions, we felt we had to do the heavy lifting first,” Anthopoulos said. “You worry about our depth and the quality of our depth. That’s normal for any club. Health, like anything else. It’s a competitive advantage to stay healthy, both from a COVID standpoint and just a playing standpoint. That’s my No. 1 thing. What are the innings pitched and games played column, can we keep those high? That will give us the best chance to get back to the playoffs.”